X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
male (24) 24
female (22) 22
index medicus (21) 21
middle aged (18) 18
aged (12) 12
atherosclerosis (10) 10
expression (10) 10
adult (9) 9
atorvastatin (8) 8
gene expression (8) 8
medical laboratory technology (8) 8
plasma (7) 7
analysis (6) 6
animals (6) 6
coronary atherosclerosis (6) 6
inflammation (6) 6
internal medicine (6) 6
lipoprotein lipase (6) 6
pharmacology & pharmacy (6) 6
rna, messenger - genetics (6) 6
carcinoma, non-small-cell lung - enzymology (5) 5
cardiovascular diseases (5) 5
care and treatment (5) 5
cathepsin s (5) 5
cell-free nucleic acids (5) 5
lipids (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - enzymology (5) 5
medicine, research & experimental (5) 5
messenger-rna (5) 5
oxidative stress (5) 5
pharmacy (5) 5
rna, messenger - blood (5) 5
aged, 80 and over (4) 4
angina, stable - blood (4) 4
aorta, thoracic - drug effects (4) 4
bilirubin (4) 4
biochemistry & molecular biology (4) 4
c-reactive protein (4) 4
carcinoma, non-small-cell lung - pathology (4) 4
cathepsin-s (4) 4
ccl2 (4) 4
enzyme activity (4) 4
enzymes (4) 4
genetic aspects (4) 4
health aspects (4) 4
heart-disease (4) 4
katepsin s (4) 4
kidney diseases (4) 4
lipoproteins (4) 4
losartan (4) 4
lung cancer tissue (4) 4
lung neoplasms - pathology (4) 4
medicine, general & internal (4) 4
metabolism (4) 4
rats (4) 4
rats, wistar (4) 4
risk factors (4) 4
serum (4) 4
smooth-muscle-cells (4) 4
statins (4) 4
universities and colleges (4) 4
angina, stable - drug therapy (3) 3
angina, stable - genetics (3) 3
angiotensin ii type 1 receptor blockers - administration & dosage (3) 3
aorta, thoracic - metabolism (3) 3
atorvastatin calcium (3) 3
bezafibrate (3) 3
biochemistry (3) 3
biomarkers (3) 3
cathepsins - genetics (3) 3
cholesterol (3) 3
coronary artery disease - blood (3) 3
dapk1 (3) 3
development and progression (3) 3
disease (3) 3
drug therapy, combination (3) 3
fluvastatin (3) 3
hemodialysis (3) 3
hyperlipidemia (3) 3
ldl (3) 3
lipoprotein lipase - metabolism (3) 3
messenger rna (3) 3
mrna in plasma (3) 3
myocardial-infarction (3) 3
nitric oxide synthase type iii - metabolism (3) 3
nucleic-acids (3) 3
original paper (3) 3
patient outcomes (3) 3
patients (3) 3
prevention (3) 3
prognosis (3) 3
prospective studies (3) 3
prostate-cancer (3) 3
proteases (3) 3
reverse transcriptase polymerase chain reaction (3) 3
risk (3) 3
stable angina (3) 3
survival analysis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Vascular Pharmacology, ISSN 1537-1891, 12/2017, Volume 99, pp. 45 - 52
Statins and sartans can, in therapeutic doses, induce pleiotropic cardiovascular effects. Similar has recently been shown also for sub-therapeutic doses. We... 
Sartans | Endothelium-dependent relaxation | Combination | Therapeutic doses | Rats | Ischaemia-reperfusion injury | Sub-therapeutic doses | Statins | HYPERLIPIDEMIC RABBITS | LOSARTAN | REDUCTASE INHIBITOR | II RECEPTOR ANTAGONIST | RELAXATION | ATORVASTATIN | INFLAMMATION | ARTERIAL-WALL | PHARMACOLOGY & PHARMACY | ISCHEMIC-REPERFUSION INJURY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Valsartan - administration & dosage | Rats, Wistar | Cholesterol - blood | Fatty Acids, Monounsaturated - administration & dosage | Male | Arginine - analogs & derivatives | Indoles - administration & dosage | Dose-Response Relationship, Drug | Myocardial Reperfusion Injury - pathology | Time Factors | Myocardium - metabolism | Female | Blood Pressure - drug effects | Aorta, Thoracic - drug effects | Nitric Oxide Synthase Type III - metabolism | Drug Therapy, Combination | Myocardial Reperfusion Injury - blood | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Disease Models, Animal | Nitric Oxide - blood | Aorta, Thoracic - metabolism | Myocardium - pathology | Aorta, Thoracic - physiopathology | Receptor, Endothelin A - genetics | Nitric Oxide Synthase Type III - genetics | Myocardial Reperfusion Injury - physiopathology | Animals | Arginine - blood | Heart - drug effects | Receptor, Endothelin A - metabolism | Coronary Circulation - drug effects | Vasodilation - drug effects | In Vitro Techniques | Myocardial Reperfusion Injury - prevention & control | Endothelin | Gene expression | Health aspects | Nitric oxide | Endothelium | Index Medicus
Journal Article
Journal of Medical Biochemistry, ISSN 1452-8258, 01/2018, Volume 37, Issue 1, pp. 54 - 61
Journal Article
Journal Article
Farmacevtski Vestnik, ISSN 0014-8229, 06/2010, Volume 61, Issue 3, pp. 144 - 148
Journal Article
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 07/2016, Volume 68, Issue 1, pp. 74 - 80
Treatment with low, subtherapeutic doses of statins and sartans expresses beneficial pleiotropic effects on the arterial wall. The present study explored... 
Journal Article
Clinical Biochemistry, ISSN 0009-9120, 2011, Volume 44, Issue 5, pp. 438 - 440
Journal Article
Journal Article